11,300 Shares in The Pennant Group, Inc. (NASDAQ:PNTG) Bought by Versor Investments LP

Versor Investments LP purchased a new stake in shares of The Pennant Group, Inc. (NASDAQ:PNTG) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 11,300 shares of the company’s stock, valued at approximately $300,000.

Several other institutional investors have also added to or reduced their stakes in PNTG. Proficio Capital Partners LLC bought a new position in shares of The Pennant Group during the fourth quarter valued at about $487,000. Bank of New York Mellon Corp increased its holdings in The Pennant Group by 3.0% during the 4th quarter. Bank of New York Mellon Corp now owns 110,963 shares of the company’s stock valued at $2,943,000 after purchasing an additional 3,233 shares during the period. Navellier & Associates Inc. raised its position in The Pennant Group by 86.3% during the 4th quarter. Navellier & Associates Inc. now owns 45,627 shares of the company’s stock valued at $1,210,000 after purchasing an additional 21,141 shares during the last quarter. Van Berkom & Associates Inc. lifted its holdings in The Pennant Group by 2,635.6% in the 4th quarter. Van Berkom & Associates Inc. now owns 2,198,216 shares of the company’s stock worth $58,297,000 after buying an additional 2,117,859 shares during the period. Finally, Hussman Strategic Advisors Inc. bought a new stake in shares of The Pennant Group in the 4th quarter worth approximately $1,114,000. Hedge funds and other institutional investors own 85.88% of the company’s stock.

The Pennant Group Stock Performance

Shares of The Pennant Group stock opened at $22.53 on Tuesday. The Pennant Group, Inc. has a 12 month low of $18.12 and a 12 month high of $37.13. The firm has a market capitalization of $773.86 million, a P/E ratio of 33.13, a P/E/G ratio of 2.24 and a beta of 1.91. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 0.58. The business has a fifty day simple moving average of $26.51 and a two-hundred day simple moving average of $30.48.

Analyst Upgrades and Downgrades

PNTG has been the subject of a number of recent analyst reports. Truist Financial decreased their target price on The Pennant Group from $38.00 to $32.00 and set a “hold” rating for the company in a report on Monday, January 6th. Wells Fargo & Company began coverage on shares of The Pennant Group in a report on Thursday, December 19th. They issued an “equal weight” rating and a $33.00 price objective for the company. Finally, Oppenheimer lifted their target price on shares of The Pennant Group from $34.00 to $37.00 and gave the company an “outperform” rating in a research note on Friday, November 8th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $36.00.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.